Company news

XOMA Royalty Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset

June 21, 2023

XOMA Declares Quarterly Preferred Stock Dividends

June 19, 2023

XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy

May 8, 2023

XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio

March 29, 2023

XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy

March 8, 2023

XOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 5, 2023

New Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy

January 3, 2023

XOMA Reports Third Quarter 2022 Financial Results and Highlights Recent Operational Events

November 2, 2022

XOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events

August 3, 2022

XOMA Reports First Quarter 2022 Financial Results and Highlights Recent Operational Events

May 4, 2022

XOMA Announces Evolution of Company Leadership and Succession Planning

December 15, 2021

XOMA Reports Third Quarter 2021 Financial Results and Highlights Recent Operational Events

November 3, 2021

XOMA Announces Heather L. Franklin Joins its Board of Directors

August 9, 2021

XOMA Reports Second Quarter 2021 Financial Results and Highlights Recent Operational Events

August 4, 2021

XOMA Acquires Royalty and Milestone Interest in Checkmate’s Vidutolimod (CMP-001) from Kuros Biosciences

July 14, 2021

XOMA Reports First Quarter 2021 Financial Results and Highlights Recent Operational Events

May 5, 2021

XOMA Earns Milestone for First Patient Dosed in Phase 3 Development Program

May 2, 2021

XOMA Announces Closing of Depositary Shares Offering and Exercise of Underwriters’ Option

April 11, 2021

XOMA Announces Offering of Depositary Shares and Series B Cumulative Perpetual Preferred Stock

April 4, 2021

XOMA Announces Approval of First Preferred Stock Dividend

March 21, 2021

XOMA Reports Fourth Quarter and Full-Year 2020 Financial Results and Operating Highlights

March 9, 2021

XOMA Announces Exercise of Green Shoe Option and Closes Preferred Stock Offering

December 20, 2020

XOMA Prices $22 Million Offering of Series A Cumulative Perpetual Preferred Stock

December 9, 2020

XOMA Announces Offering of Series A Cumulative Perpetual Preferred Stock

December 9, 2020

XOMA Earns $2 Million Milestone from Takeda as Mezagitamab Advances into Phase 2 Development

November 15, 2020

XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement

November 10, 2020

XOMA Acquires Royalty Interest in Four Lysosomal Storage Disorder Enzymes Being Developed Under the Chiesi Group–Bioasis Strategic Alliance

November 2, 2020

XOMA Earns $25 Million Milestone Payment as Anti-TGFβ Antibody Enters Phase 2 Clinical Study in Metastatic Pancreatic Cancer

October 27, 2020

XOMA Earns $1.9 Million Associated with Two Partner Developments

October 13, 2020

XOMA Reports Second Quarter 2020 Financial Results

August 5, 2020

XOMA Announces Natasha Hernday Joins its Board of Directors

June 30, 2020

XOMA Reports First Quarter 2020 Financial Results and Provides COVID-19 Business Update

May 4, 2020

XOMA Reports Fourth Quarter and Full-Year 2019 Financial Results and Operating Highlights

March 9, 2020

XOMA Announces Closing of Rights Offering

December 19, 2019

XOMA Announces Commencement of Rights Offering

December 1, 2019

XOMA Announces Proposed Rights Offering

November 18, 2019

CORRECTING and REPLACING -- XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results

November 4, 2019

← Newer news releases

Calls

Decks

The 5 newest of 58 decks. Every deck is listed under its year.